方法：将40只大鼠随机分为对照组、4.25％腹膜透析液(peritoneal dialysis fluid,PDF)组、低剂量丹参酮ⅡA(丹参酮ⅡA终浓度为50 mg·L-1)组、高剂量丹参酮ⅡA(丹参酮ⅡA终浓度为...
基于4个网页-相关网页
The problem is solved by a peritoneal dialysis fluid containing substances selected from cyclonigerosyl nigerose.
含有黑曲霉糖的腹膜透析液能够解决这个问题。
The object is solved by a peritoneal dialysis fluid containing one or more substances selected from cyclonigerosyl nigerose, cyclomaltosyl maltose and L-ascorbic acid 2-glucoside.
该技术问题通过提供含有一种或两种以上选自环黑曲霉 糖基黑曲霉糖、环麦芽糖基麦芽糖以及L-抗坏血酸2-葡萄糖苷的腹膜透析液得 到解决。
An object of the invention is to provide a peritoneal dialysis fluid, which is excellent in a water removal ability, has high biocompatibility, and is excellent in storage stability.
本发明要解决的技术问题是提供一种脱水性良好、生物适应性高和存储稳定性好的腹膜透析液。
应用推荐